To The Moon

$POP MART(09992)$ 's IP magic working! New blind boxes selling out + global expansion booming. Gen-Z spending power is unreal - this trendsetter keeps delivering!

$Exxon Mobil(XOM)$ delivering steady gains! Oil recovery + juicy dividends = perfect combo. Energy giant showing its strength - collecting dividends while waiting for the next pop!

$Direxion Daily Energy Bull 2x Shares(ERX)$ 's wild ride continues! Oil prices jumped around, up yesterday down today. Glad I got in early - energy sector moves fast, pocketing gains and waiting for next chance!

$Direxion Daily S&P Biotech Bull 3x Shares(LABU)$ 's wild ride continues! Monday +8% on FDA news, yesterday -5% profit-taking. Leveraged ETF volatility at its best - M&A rumors still brewing, holding through the storm!

$Taiwan Semiconductor Manufacturing(TSM)$ I am thankful to be able to have held onto TSMC despite cyclical stock movements. I believe this is an important company with a wide economic moat. Hope to be able to spot and add when there's corrections [Happy]  

$FUTU 20250822 170.0 PUT$  Futu is a beast. More pocket $ [Miser]  

$NVIDIA(NVDA)$ a bit pull back but staying confident

Closing my position on $TGT 20250905 105.0 PUT$ bought prior to $Target(TGT)$  earning's results.  The earnings release met the already lowered targets, however Target announced that longtime veteran and current Chief Operating Officer Michael Fiddelke will succeed CEO Brian Cornell on Feb. 1. Cornell will then transition to the role of executive chair of Targets board of directors. This added uneaseness and loss of confidence in investors.

$SNDL 20270115 2.0 CALL$ the calculated risk of covered call. It is fine, part if a process... 

$XPENG-W(09868)$  Time to take        a bit of profits after a solid run up these few      days. The company has great potential n the market share is growing at a fast pace indeed. The chief even increased his stake in the        company. This shows the confidence level the prospect of potential growth in the company. Good luck Tigers.

$TENCENT(00700)$ Let's hope it stays above HKD 600...

$PANW 20250822 190.0 CALL$ closed the SC ahead of Friday Jackson Hole event. 

$SMMT 20250822 25.0 PUT$ Summit Therapeutics（SMMT）憑藉依沃西（Ivonescimab, AK112）與強大財務實力，展現投資潛力。依沃西在HARMONi-2三期試驗中PFS達11.14個月，優於Keytruda的5.82個月，降低49%疾病進展風險，有望成非小細胞肺癌一線治療，2025年初將啟動全球HARMONi-7試驗。公司現金儲備4.869億美元，新增2.35億美元融資，支撐多項三期試驗。與康方生物合作，獲北美、歐洲、日本市場權益，依沃西已於2024年5月及2025年4月獲中國NMPA批准兩項適應症，商業化加速。分析師給予買入評級，目標價31美元。儘管OS數據待2025年中公佈，依沃西的技術優勢和資金支持降低風險。SMMT適合看好生物科技的投資者，長期價值可期。我長期沽出其認沽期權做好！

$WeRide Inc.(WRD)$   🚨 Critical Review: WeRide’s Partnership with Grab WeRide’s much-touted partnership with Grab has been marketed as a breakthrough for autonomous mobility in Southeast Asia, but a closer look raises more red flags than opportunities. 1. Execution Risks in Emerging Markets Grab operates in markets with poor infrastructure, inconsistent regulations, and unpredictable traffic conditions. Rolling out autonomous vehicles in such environments will be far more complex than in the U.S. or China. The likelihood of operational delays, safety issues, and regulatory pushback is high. 2. Regulatory Uncertainty Unlike China or the U.S., Southeast Asia does not have a mature autonomous vehicle regulatory fram

The upcoming Jackson Hole symposium presents a complex and high-stakes scenario for markets, and while there are some similarities to 2022, the context is different in crucial ways. Comparison to Jackson Hole 2022 The most notable similarity is the presence of high inflation and a strong interest rate environment. In August 2022, the Fed was in the midst of an aggressive rate-hiking cycle, with rates at 2.25%-2.50% and climbing. Fed Chair Jerome Powell's speech was famously short and hawkish, explicitly stating that the Fed was committed to bringing down inflation, even at the cost of "some pain" for the economy. This stance crushed market hopes for a quick policy pivot and led to a sharp sell-off in both stocks and bonds. Now, in August 2025, the U.S. has seen an aggressive rate-hiking cy